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Original Studies
Background: Young children are at increased risk of severe outcomes from 
influenza illness, including hospitalization. We conducted a case-control 
study to identify risk factors for influenza-associated hospitalizations 
among children in US Emerging Infections Program sites.
Methods: Cases were children 6–59 months of age hospitalized for 
 laboratory-confirmed influenza infections during 2005–2008. Age- and 
 zip-code-matched controls were enrolled. Data on child, caregiver and 
household characteristics were collected from parents and medical records. 
Conditional logistic regression was used to identify independent risk factors 
for hospitalization.
Results: We enrolled 290 (64%) of 454 eligible cases and 1089 (49%) of 
2204 eligible controls. Risk for influenza hospitalization increased with 
maternal age <26 years [odds ratio (OR): 1.8, 95% confidence interval 
(CI): 1.1–2.9]; household income below the poverty threshold (OR: 2.2, 
95% CI: 1.4–3.6); smoking by >50% of household members (OR: 2.9, 95% 
CI: 1.4–6.6); lack of household influenza vaccination (OR: 1.8, 95% CI: 
1.2–2.5) and presence of chronic illnesses, including hematologic/oncologic 
(OR: 11.8, 95% CI: 4.5–31.0), pulmonary (OR: 2.9, 95% CI: 1.9–4.4) and 
neurologic (OR: 3.8, 95% CI: 1.6–9.2) conditions. Full influenza immuniza-
tion decreased the risk among children 6–23 months of age (OR: 0.5, 95% 
CI: 0.3–0.9) but not among those 24–59 months of age (OR: 1.5, 95% CI: 
0.8–3.0; P value for difference = 0.01).
Conclusions: Chronic illnesses, young maternal age, poverty, household smok-
ing and lack of household influenza vaccination increased the risk of influenza 
hospitalization. These characteristics may help providers to identify young 
 children who are at greatest risk for severe outcomes from influenza illness.
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Compared with older children and adults, young children, especially those <2 years of age, are at increased risk for 
 influenza-associated complications, including hospitalization.1–6 
Characteristics previously identified to increase the risk of severe 
outcomes from seasonal influenza illness include male gender,4 age 
<12 months,4 gestational age <37 weeks7 and underlying medical 
conditions including pulmonary,7,8 neurologic/neuromuscular dis-
ease8,9 or cardiac conditions.7–9
Few studies have had sufficient power to assess whether 
social and economic factors such as daycare attendance, car-
egiver education level, crowding and poverty increase the risk of 
severe outcomes. The Emerging Infections Program (EIP)10 of the 
US Centers for Disease Control and Prevention (CDC) is a col-
laboration of federal, state and local academic and public health 
partners that conducts  population-based surveillance in 10 states, 
including surveillance for laboratory-confirmed pediatric influ-
enza hospitalizations. During 2005–2008, the EIP network con-
ducted a  case-control study to assess the vaccine effectiveness of 
 trivalent-inactivated vaccine in preventing influenza-associated 
hospitalizations among young children. In this analysis, we sought 
to identify child, household and caregiver factors associated with 
hospitalizations because of laboratory-confirmed influenza among 
children who are recommended to receive the influenza vaccine 
(children 6–59 months of age).
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MATERIALS AND METHODS
Study Population
The study population was drawn from children residing in 
selected counties in 9 states that participated in EIP surveillance for 
influenza hospitalizations: California, Colorado, Connecticut, Geor-
gia, Minnesota, New Mexico, New York, Oregon and Tennessee (see 
Appendix). The catchment area represented approximately 9% of all 
US children <5 years of age, and the counties from which study sub-
jects were enrolled are highlighted in Figure 1. The age criteria for 
inclusion were based on the current Advisory Committee on Immuni-
zation Practices recommendations for influenza vaccination: during 
2005–2006, children 6–23 months of age were included,11 and during 
2006–2008, children 6–59 months of age were included because of 
revised Advisory Committee on Immunization Practices recommen-
dations.12 Children were considered eligible for enrollment if they 
were in the appropriate age range on October 1st of each season.
Case and Control Identification
A case was defined as a child who was hospitalized with 
a respiratory illness within 14 days of testing positive with a 
 clinician-ordered laboratory test for an influenza infection. Accept-
able laboratory tests for influenza included commercially available 
rapid diagnostic tests, immunofluorescence antibody staining, reverse 
transcription polymerase chain reaction or viral culture. For each case 
enrolled, up to 4 control children from the community who had not 
been hospitalized with laboratory-confirmed influenza or a respira-
tory illness during that influenza season were enrolled. Controls were 
identified through birth certificate registry files and were matched to 
the case’s date of birth (±2 weeks). Controls were also matched by area 
of residence, by using the case’s zip code of residence at admission 
and identifying controls whose mother resided in that zip code or an 
adjacent zip code, as recorded on the child’s birth certificate. Data on 
whether control children were hospitalized with  laboratory-confirmed 
influenza or a respiratory illness during that influenza season were 
collected by self-report from the control child’s caregiver.
Data Collection
After obtaining caregiver consent, study personnel con-
ducted a standardized telephone interview in English or Spanish 
within 120 days of the hospitalized case child’s admission date. 
Caregivers were interviewed about child characteristics, household 
characteristics and caregiver characteristics. For variables that may 
have changed with time, questions focused on a reference period 
defined for cases as 30 days before admission and for controls as 
the calendar month that most closely overlapped with the corre-
sponding case’s reference period. The child’s primary care provid-
ers were contacted to collect data on vaccination status (including 
dates of administration for all routine vaccines, including influenza 
vaccine) and the diagnosis of medical conditions.
Definitions
The start of each influenza season was determined at each 
local site, generally as the first week after October 1st of each year 
in which influenza-like illness had increased for at least 2 weeks 
and culture- or RT-PCR-confirmed influenza infections were 
reported by local hospitals or the state public health laboratory. The 
end of the season was set as April 30th of each year.
Parents were asked to identify their child’s race and ethnic-
ity by categories that were defined by the investigators; data on 
race and ethnicity were collected because they have been associ-
ated with the risk of hospital admission among children and may 
be proxies for other possible risk factors for hospitalization, includ-
ing socioeconomic status. Children were considered immunized if 
they received influenza vaccine after September 1st and at least 14 
days before the date of case admission. Children were defined as 
fully immunized for influenza if they received either 2 doses since 
September 1st of the current season or 1 dose in the current season 
but at least 2 doses in any prior season and not fully immunized if 
they received only a single dose since September 1st of the current 
season and 0–1 doses in a prior season or if they received no doses 
since September 1st of the current season.12
FIGURE 1. Participating Emerging Infections Program sites, color coded by season(s) of participation, 2005-2008.
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Household poverty status was defined using US Census 
Bureau poverty thresholds for 2007 by size of family and num-
ber of related children <18 years of age.13 A household crowd-
ing index was determined for each child using the Equivalized 
Crowding Index.14 This index is calculated using household com-
position and the number of separate bedrooms as follows: [(1/2 
number of children <10 years of age) + (number of couples) + (all 
other people ≥10 years of age)]/number of bedrooms. We defined 
crowded for this study as greater than the median value for all 
households surveyed.
Data Analysis
Analyses were conducted using conditional logistic regres-
sion to identify factors associated with influenza hospitalizations, 
stratifying by the matching variables of age and zip code. A con-
ditional logistic regression model was built using all identified risk 
factors with P < 0.1, including influenza immunization status and 
possible effect modifiers. The main effects model was reduced by 
removing the least significant variables one at a time from a full 
model, provided that removing the variable did not change an odds 
ratio (OR) for any retained variables by ≥10%.15 Subsequently, 
three 2-way interaction terms (child age and household member 
influenza vaccination status, child influenza vaccination status and 
household member influenza vaccination status and child age and 
child influenza vaccination status) and one 3-way interaction term 
(child influenza vaccination status, household member influenza 
vaccination status and child age) were added to the model, and 
the model was reduced further by removing the least significant 
product terms beginning with the 3-way interaction, provided that 
removing the product term did not change an OR for any retained 
main effects variable by ≥15% (see Appendix for model code). ORs 
with P < 0.05 were considered statistically significant in the final 
model. All statistical analyses were conducted using SAS Version 
9.1 (SAS Institute, Cary, NC).
Human Subjects
The CDC determined that this assessment did not constitute 
research but rather represented the evaluation of a vaccine program 
for public health purposes. This project therefore did not need Insti-
tutional Review Board approval at CDC. If required by the state, 
participating EIP sites submitted the study to their state IRBs for 
review and approval.
RESULTS
Over 3 influenza seasons, 290 (64%) of 454 eligible cases 
and 1089 (49%) of 2204 eligible controls were enrolled from 9 
states after parental consent was obtained (Table 1). Among all 
children enrolled, 191 (14%) were enrolled in 2005–2006, 439 
(32%) in 2006–2007 and 749 (54%) in 2007–2008. The median 
age was 20 months (range 6.01–59.6); 60% were 6–23 months 
of age and 40% were 24–59 months of age. The number of cases 
enrolled in each season by week of hospital admission is shown 
in Figure 2. The most common influenza diagnostic tests used to 
confirm influenza infection included rapid diagnostic test (57%), 
immunofluorescence antibody staining (29%), viral culture (7%) 
and reverse transcription polymerase chain reaction (4%). The 
mean time between each case’s hospital admission date and the 
positive influenza test result was 1.4 hours (standard deviation ± 
26.2). The median number of days from case admission to case 
and control interviews was 53.5 (range 7–148) and 113.5 (range 
TABLE 1. Number of Case Children in Each Age Group 
by Enrollment Site
State
6–23 months 
(2005–2008)
24–59 months 
(2006–2008) Total
CA 18 12 30
CO 29 16 45
CT 24 16 40
GA 20 20 40
MN 32 24 56
NM 6 4 10
NY 6 6 12
OR 28 16 44
TN 12 1 13
Total 175 115 290
FIGURE 2. Number of cases of 
hospitalized laboratory-confirmed 
influenza identified by week of 
influenza season by the Emerging 
Infections Program, 2005-2008.
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15–278), respectively. Enrolled cases were slightly older than eli-
gible cases who were not enrolled (mean age: 24 vs. 20 months; 
P = 0.003) and more likely to be white than non-white (56% 
vs. 28%; P < 0.001), but no significant differences by sex, black 
race or Hispanic ethnicity, length of hospitalization or number of 
medical conditions were found.
Children who were male, of Hispanic ethnicity, black race 
or low birth weight were at increased risk of hospitalization with 
laboratory-confirmed influenza (Table 2). Children who were never 
breast-fed were also at increased risk, but whether the child was 
breast-fed during the reference period or not was not significant 
(data not shown). Breast-feeding for ≥6 months was protective 
among infants, reducing risk of hospitalization by ≥50%, compared 
with never being breast-fed. Not having private insurance and not 
being fully vaccinated for influenza were also identified as risk fac-
tors for hospital admission with influenza.
Daycare attendance was not a risk factor for hospital admis-
sion with influenza. The number of hours per week in daycare, 
TABLE 2. Matched Univariate Analysis of Child Risk Factors for Hospitalization With 
Laboratory-confirmed Influenza Virus Infection Compared With Community Controls
Risk Factor
Cases (N = 290) Controls (N = 1089) 
OR (95% CI) P Value*n (%) n (%)
Gender
  Female 123 (42) 543 (50) Ref
  Male 167 (58) 546 (50) 1.3 (1.0–1.8) 0.04
  Missing 0 0
Hispanic
  No 194 (67) 794 (73) Ref
  Yes 96 (33) 293 (27) 1.4 (1.0–2.0) 0.04
  Unknown 0 2 (0.2)
  Missing 0 0
Race
  White only 190 (66) 798 (73) Ref
  Black only 45 (16) 91 (8) 2.6 (1.6–4.2) 0.0001
  Asian only 9 (3) 45 (4) 0.9 (0.4–1.9) 0.73
  Hawaiian/Pacific Islander only 0 5 (0.5) N/A 0.98
  American Indian/Alaska Native only 1 (0.3) 4 (0.4) 0.7 (0.1–6.6) 0.75
  Other race only† 19 (7) 53 (5) 1.6 (0.9–3.0) 0.12
  Multiracial‡ 24 (8) 88 (8) 1.2 (0.7–2.0) 0.48
  Unknown 0 3 (0.3)
  Refused 1 (0.3) 1 (0.1)
  Did not indicate any race 1 (0.3) 1 (0.1)
  Missing 0 0
Birth weight§
  Normal and overweight (>2500 g) 250 (86) 1026 (94) Ref
  Low birth weight (1501–2500 g) 25 (9) 44 (4) 2.3 (1.3–4.0) 0.003
  Very low (≤1500 g) 10 (3) 16 (1) 2.2 (0.9–5.2) 0.10
  Unknown 5 (2) 3 (0.3)
  Missing 0 0
Ever breast-fed
  Yes 214 (74) 902 (83) Ref
  No 74 (26) 186 (17) 1.8 (1.3–2.4) 0.001
  Unknown 2 (0.7) 0
  Missing 0 1
If breast-fed, age in months all breast-feeding  
was stopped, median (range)
6 (0–36) 6 (0–36)
Duration of breast-feeding
  Patients 6–23 months of age n = 175 n = 651
  Never breast-fed 44 (25) 115 (18) Ref
  0–5 months 62 (35) 199 (31) 0.7 (0.5–1.2) 0.22
  6–11 months 32 (18) 158 (24) 0.5 (0.3–0.8) 0.008
 ≥12 months 16 (9) 106 (16) 0.3 (0.2–0.6) 0.001
  Still breast-feeding 7 (4) 23 (4)
  Unknown 12 (7) 32 (5)
  Missing 2 (1) 18 (3)
  Patients 24–59 months of age n = 115 n = 438
  Never breast-fed 30 (26) 71 (16) Ref
  0–5 months 33 (29) 118 (27) 0.7 (0.4–1.2) 0.15
  6–11 months 25 (22) 115 (26) 0.5 (0.3–0.9) 0.03
 ≥12 months 26 (23) 132 (30) 0.5 (0.3–0.8) 0.01
  Still breast-feeding 0 0
  Unknown 1 (0.9) 2 (0.5)
  Missing 0 0
(Continued)
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Health insurance
  Private 150 (52) 748 (69) Ref
  Not private (government, none, other) 140 (48) 340 (31) 2.5 (1.8–3.4) <0.0001
  Unknown 0 1 (0.1)
  Missing 0 0
Vaccination status (other than influenza)
  Completely up to date¶ 81 (28) 345 (32) Ref
  Up to date, except for Hepatitis B 66 (23) 221 (20) 1.4 (0.9–2.1) 0.17
  Up to date only for DTP, MMR and  
  pneumococcal vaccinations
45 (16) 199 (18) 0.99 (0.6–1.7) 0.99
  Other 98 (34) 324 (30) 1.4 (0.9–2.1) 0.11
Vaccinated for influenza
  Fully vaccinated 52 (18) 294 (27) Ref
  Not fully vaccinated 238 (82) 795 (73) 1.7 (1.2–2.4) 0.004
  Missing 0 0
Attended daycare during reference period
  No 174 (60) 666 (61) Ref
  Yes 115 (40) 423 (39) 1.1 (0.8–1.4) 0.71
  Unknown 1 (0.3) 0
  Missing 0 0
Daycare type
  No daycare 174 (60) 666 (61) Ref
  Daycare center 39 (13) 117 (11) 1.2 (0.8–1.9) 0.29
  Preschool 41 (14) 162 (15) 1.0 (0.6–1.6) 0.95
  Home daycare 32 (11) 139 (13) 0.9 (0.6–1.4) 0.63
  Other 3 (1) 5 (.5) 2.6 (0.6–12.0) 0.22
  Unknown 1 (0.3) 0
  Missing 0 0
Presence of underlying medical condition
  No 154 (53) 914 (84) Ref
  Yes 136 (47) 175 (16) 5.1 (3.7–7.0) <0.0001
  Missing 0 0
Number of medical conditions
  0 154 (53) 914 (84) Ref
  1 85 (29) 157 (14) 3.6 (2.6–5.1) <0.0001
  >1 51 (18) 18 (2) 17.7 (9.7–32.5) <0.0001
  Missing 0 0
Type of underlying medical condition
  No underlying medical condition 154 (53) 914 (84) Ref
  Multiple underlying medical conditions 51 (18) 18 (2) 17.6 (9.6–32.3) <0.0001
  Pulmonary‖ condition(s) only 66 (23) 127 (12) 3.5 (2.4–5.0) <0.0001
  Hematologic/oncologic** condition(s) only 10 (3) 8 (0.7) 7.6 (2.7–21.3) 0.0001
  Neurologic‡‡ condition(s) only 5 (2) 7 (0.7) 4.4 (1.3–15.1) 0.02
  Cardiac condition(s) only 1 (0.3) 7 (0.6) 1.6 (0.2–14.1) 0.67
  Diabetes only 1 (0.3) 0 N/A 0.99
  Chronic kidney condition(s) only 0 4 (0.4) N/A 0.98
  Other chronic medical condition(s) only 2 (0.7) 4 (0.4) 3.5 (0.6–21.3) 0.17
N/A, not applicable; DTP, diphtheria-tetanus toxoids-pertussis; MMR, measles-mumps-rubella.
*All P values are computed exact except for the following variables: race, duration of breast-feeding, type of underlying medical condition, age of 
mother/stepmother, percent of persons in the household that received the influenza vaccine.
†Sixty-nine (96%) of patients who reported “other race” also described themselves as Hispanic. Of the 3 (4%) who did not describe themselves as 
Hispanic, 1 described themselves as “Indian”, 1 as “African” and 1 as “unknown”.
‡Self-described as >1 race.
§Birth weight taken from birth certificates unless unavailable; then as reported by the caregiver.
¶Definition of up to date vaccinations: receipt of all recommended childhood vaccinations except influenza vaccine, based on child’s age on 
 enrollment.
‖Chronic asthma condition, chronic lung condition, birth defect or chronic condition making breathing or swallowing difficult, condition requiring 
equipment for breathing or handling secretions, condition that an operation was done to make breathing/secretions easier and condition requiring 
surgery or equipment for breathing/secretions.
**Sickle cell disease, malignancy, history of bone marrow or organ transplant, chronic immunologic condition.
‡‡Spinal cord injury, history of seizure, severe developmental delay or mental retardation.
TABLE 2. Continued
Risk Factor
Cases (N = 290) Controls (N = 1089) 
OR (95% CI) P Value*n (%) n (%)
daycare attendance during the reference period, duration of time 
spent in daycare before the reference period and the number of chil-
dren in the same room with the child in daycare were not associated 
with admission (data not shown). Data on sibling daycare attend-
ance were not collected.
Detailed information on the prevalence of chronic under-
lying medical conditions among study participants is presented 
in Table 3. Having 1 or more chronic illnesses was a risk factor 
for hospitalization (Table 2) and pulmonary, hematologic/onco-
logic and neurologic conditions were identified as statistically 
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significant risk factors. Although most children with any chronic 
illness had only 1 condition, the risk of hospitalization increased 
17-fold if the child had >1 underlying medical conditions com-
pared with none.
Caregiver and household characteristics associated with 
an increased risk of hospitalization are listed in Table 4. Hav-
ing a mother or caregiver <26 years of age was a risk factor 
compared with a reference group 26–35 years of age, and hav-
ing a caregiver ≥36 years of age old was protective. Having a 
caregiver with less than some college attendance and living in a 
non-single family home were identified as risk factors. A house-
hold crowding index greater than the median (0.75), having >1 
person/bedroom in the household or ≥2 children sleeping in the 
same bedroom with the study child were risk factors. Although 
the absolute number of smokers in the household was not an 
identified risk factor, having a high proportion of persons liv-
ing in the household who reported smoking (>50%) was. Very 
few household members reported smoking inside the home (data 
not shown). Influenza vaccination of any household member 
decreased the risk of hospitalization. Household income <2 
times the poverty threshold increased the risk of hospitaliza-
tion, and this risk increased substantially as household income 
decreased to below the poverty threshold.
In multivariable analyses, factors associated with influenza 
hospitalization were identified in a main effects model (Table 5). 
A final multivariable model including an interaction term between 
child age and child influenza immunization status was constructed 
(Table 6). Independent factors associated with influenza hospi-
talization included: maternal age <26 years, household income 
below the poverty threshold, the presence of specific chronic 
illnesses (including hematologic or oncologic, pulmonary and 
neurologic conditions), lack of a household member being vac-
cinated for influenza and >50% household members who reported 
smoking (Table 6). A significant interaction (P = 0.01) was identi-
fied between child age and child influenza immunization status 
(Table 6). Full immunization of the child for influenza decreased 
the risk of hospitalization among children 6–23 months of age 
[OR: 0.5, 95% confidence interval (CI): 0.3–0.9; P = 0.01], but 
not among children 24–59 months of age (OR: 1.5, 95% CI: 0.8–
3.0; P = 0.24).
DISCUSSION
We identified a number of factors that increased the risk of 
hospitalization for influenza among children 6–59 months of age 
in the EIP population during 3 consecutive US influenza seasons. 
Maternal age <26 years, household income below the poverty 
threshold, lack of household member influenza vaccination and 
smoking by >50% of household members were identified as inde-
pendent risk factors for hospitalization with laboratory-confirmed 
influenza. Consistent with prior studies,7–9 specific chronic ill-
nesses logically increased the risk for hospitalization with influ-
enza. Among younger children, full immunization for influenza 
decreased the risk of hospitalization.
Our findings that several caregiver- and household-level 
factors increased the risk of an influenza-associated hospitaliza-
tion were not unexpected. For example, an inverse relationship was 
demonstrated between maternal age and the risk of acute lower 
respiratory tract infection among children <59 months of age in a 
study conducted in Western Australia,16 and a US study found that 
maternal age <25 years was associated with increased risk of lower 
respiratory tract infection deaths among children <1 year of age.17 
Young maternal age may increase the risk of hospitalization with 
influenza because younger mothers and their peers may have less 
experiential knowledge and/or less social support. Younger women 
also may be more susceptible to respiratory infections than older 
women18 and thus may be more likely to transmit influenza infec-
tions to their young children.
We collected data for several factors related to socioeco-
nomic status, including household income, household crowding 
and receipt of Medicaid insurance. In other studies, a number of 
such indicators of low socioeconomic status have been identified 
as risk factors for hospitalization with common acute infectious 
diseases among young children. For example, receiving Medicaid 
insurance has been identified as risk factors among young children 
for hospitalization with rotavirus gastroenteritis.19,20 In our analysis, 
only household income was identified as an independent risk fac-
tor for an influenza hospitalization, suggesting it may be a more 
encompassing predictor of risk than type of insurance. Low fam-
ily income has been shown to increase the risk of lower respira-
tory tract infections, asthma attacks and respiratory-related hospi-
talizations among children21 and has been associated with worse 
outcomes in infants with respiratory syncytial virus infection.22 A 
TABLE 3. Underlying Medical Conditions of Study 
Participants
Underlying Medical  
Conditions
Cases  
(N = 290)
Controls  
(N = 1089)
n (%) n (%)
Any underlying medical  
condition
  No 154 (53) 914 (84)
  Yes 136 (47) 175 (16)
  Missing 0 0
Number of medical conditions
  0 154 (53) 914 (84)
  1 72 (25) 148 (14)
  2 28 (10) 18 (2)
  3 18 (6) 4 (0.4)
  4 12 (4) 5 (0.5)
  >4 6 (2) 0
  Missing 0 0
Type of underlying condition
  Asthma (including reactive  
  airway disease or >1 episode 
 of wheezing)
95 (33) 137 (13)
  Takes medication for wheezing,  
  reactive airway disease  
or asthma
76 (26) 91 (8)
  Takes oral or intravenous  
  steroid medications
68 (23) 58 (5)
  Condition affecting breathing  
 or swallowing*
36 (12) 20 (2)
  Severe developmental delay or  
  mental retardation
31 (11) 16 (1)
  Chronic immune condition,  
  including congenital
21 (7) 8 (0.7)
  Cardiac 14 (5) 13 (1)
  Seizure disorder 13 (4) 1 (0.1)
  Chronic pulmonary condition 12 (4) 3 (0.3)
  Malignancy 10 (3) 1 (0.1)
  Sickle cell disease 8 (3) 3 (0.3)
  Kidney disease 5 (2) 5 (0.5)
  Bone marrow or organ  
  transplant
5 (2) 0
  Diabetes 1 (0.3) 1 (0.1)
  Spinal cord injury 1 (0.3) 1 (0.1)
  Other chronic medical  
  condition
14 (5) 7 (0.6)
*Birth defect or chronic condition making breathing or swallowing difficult, condi-
tion requiring equipment for breathing or handling secretions, condition that an opera-
tion was done to make breathing/secretions easier and condition requiring surgery or 
equipment for breathing/secretions.
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TABLE 4. Matched Univariate Analysis of Caregiver and Household Risk Factors for Hospitalization With 
Laboratory-confirmed Influenza Virus Infection Compared With Community Controls
Risk Factor
Cases (N = 290) Controls (N = 1089)
OR (95% CI) P Value*n (%) n (%)
Caregiver characteristics
Mother/stepmother described as primary caregiver
  Yes 250 (86) 960 (88) Ref
  No 40 (14) 129 (12) 1.2 (0.8–1.7) 0.51
  Missing 0 0
Age of mother/stepmother, years
  16 to <22 20 (7) 38 (3) 2.2 (1.2–4.0) 0.01
  22 to <26 49 (17) 97 (9) 2.1 (1.4–3.1) 0.0004
  26 to <36 149 (51) 599 (55) Ref
 ≥36 64 (22) 347 (32) 0.7 (0.5–1.0) 0.045
  Missing 8 (3) 8 (0.7)
Primary caregiver education
  At least some college 159 (55) 750 (69) Ref
  None-Grade 12 or Certificate of High School Equivalency 127 (44) 332 (30) 2.0 (1.4–2.7) <0.0001
  Refused 4 (1) 7 (0.6)
  Missing 0 0
Household characteristics
  Type of residence
  Single family home 176 (61) 828 (76) Ref
  Other 114 (39) 261 (24) 2.5 (1.8–3.4) <0.0001
  Missing 0 0
 Crowding index†
  ≤0.75 (median) 120 (41) 618 (57) Ref
   >0.75 162 (56) 463 (43) 1.9 (1.4–2.5) <0.0001
   Missing 8 (3) 8 (0.7)
 Number of persons/bedroom
  ≤1 71 (24) 367 (34) Ref
   >1 216 (74) 719 (66) 1.6 (1.1–2.2) 0.005
   Missing 3 (1) 3 (0.3)
 Number of children sleeping in the bedroom with the child
   <2 260 (90) 1021 (94) Ref
  ≥2 29 (10) 66 (6) 1.9 (1.1–3.1) 0.02
   Missing 1 (0.3) 2 (0.2)
 Number of smokers in the household
   0 214 (74) 834 (77) Ref
   1 31 (11) 116 (11) 1.1 (0.7–1.7) 0.77
  ≥ 2 26 (9) 67 (6) 1.5 (0.9–2.5) 0.13
   Missing 19 (7) 72 (7)
 Percent of household members who are smokers
   None 214 (74) 834 (77) Ref
  ≤50% 38 (13) 152 (14) 1.0 (0.7–1.5) 1.0
   >50% 19 (7) 31 (3) 2.3 (1.2–4.3) 0.01
   Missing 19 (7) 72 (7)
 Number smokers per bedroom
   0 212 (73) 832 (76) Ref
   >0–1 51 (18) 179 (16) 1.2 (0.8–1.7) 0.48
   >1 6 (2) 4 (0.4) 6.0 (1.4–29.4) 0.01
   Missing 21 (7) 74 (7)
 Any household member received influenza vaccine
   Yes 146 (50) 655 (60) Ref
   No 135 (47) 414 (38) 1.5 (1.1–2.0) 0.007
   Unknown 9 (3) 20 (2)
   Missing 0 0
 Percent of persons in household that received influenza vaccine
  0 135 (47) 414 (38) Ref
   1–25% 26 (9) 71 (7) 1.2 (0.7–1.9) 0.58
   26–50% 54 (19) 246 (23) 0.6 (0.4–0.9) 0.02
   51–75% 31 (11) 148 (14) 0.6 (0.4–1.0) 0.04
   76–100% 35 (12) 190 (17) 0.5 (0.4–0.8) 0.005
   Unknown 9 (3) 20 (2)
   Missing 0 0
 Household income
  ≥200% poverty threshold 149 (51) 738 (68) Ref
   100% to <200% poverty threshold 39 (13) 123 (11) 1.8 (1.2–2.9) 0.009
   50% to <100% poverty threshold 54 (19) 102 (9) 3.6 (2.3–5.5) <0.0001
   <50% poverty threshold 14 (5) 39 (4) 3.0 (1.5–6.3) 0.003
   Refused 13 (4) 29 (3)
   Missing 21 (7) 58 (5)
*All P values are computed exact except for the following variables: race, duration of breast-feeding, type of underlying medical condition, age of mother/stepmother, percent of 
persons in the household that received the influenza vaccine.
†Crowding Index = [(1/2 number of persons<10 years old) + (number of couples) + (number of persons>10 years old)]/number of bedrooms.
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recent study examining risks of hospitalization with 2009 H1N1 
influenza found an inverse association between odds of hospitali-
zation and neighborhood poverty among adults and children.23 Of 
course, lower socioeconomic status is associated with other factors, 
including poor access to medical care because of lack of transpor-
tation and fewer general available resources, which might mediate 
this increased risk.24
Smoking by the mother and other household members is 
known to increase the risk of infectious and noninfectious respira-
tory illness in children. In a recent meta-analysis,25 exposure to 
smoking by any household member was associated with an OR 
of 1.5 for lower respiratory infections among children <2 years 
of age. Our findings are consistent with those of other studies 
and provide evidence that exposure to passive smoking specifi-
cally increases the risk of serious outcomes related to influenza 
infection.
Our finding that full immunization for influenza decreased 
the risk of hospitalization among younger children (6–23 months 
of age) but not among older children (24–59 months of age) was 
unexpected, but may be because of an unmeasured case ascertain-
ment bias related to differences in health-seeking behavior. Advi-
sory Committee on Immunization Practices recommendations for 
influenza vaccination were expanded during our study enrollment 
to include children in the older age group. It is possible that older 
children who received the vaccination in line with the new recom-
mendations were more likely to have seen a physician in general 
and therefore more likely to seek medical attention for a respiratory 
illness and be identified as a case.
Neither child race nor ethnicity was associated with an 
increased risk for influenza hospitalization in our case-control study. 
Although racial disparities for hospitalization associated with acute 
respiratory illness including influenza have been reported,26,27 it is 
likely that other data we collected in our study, including household 
income and the presence of specific chronic medical conditions, 
accounted for any greater risk of influenza hospitalization among 
select racial/ethnic groups. For example, other studies have found 
that black children have higher asthma prevalence,28 black and His-
panic women have lower maternal age at first parity29 and blacks 
and Hispanics have highest US poverty rates.30 It also should be 
noted that our sample size of non-Caucasian children was small, 
and therefore it is unlikely that this study was powered to detect 
small differences in risk, especially after controlling for the factors 
mentioned above.
This study has several limitations. First, cases were identi-
fied by influenza laboratory tests ordered by clinicians and not 
through use of a standardized protocol. Therefore, our results may 
not be representative of all children hospitalized (but not neces-
sarily diagnosed) with influenza. Second, the diagnostic tests used 
to diagnose influenza infection were of variable sensitivity and 
specificity. In particular, there is concern with the use of com-
mercially available influenza antigen detection assays, as the sen-
sitivity and specificity of these tests can be quite variable.31,32 In 
the context of a  case-control study, the specificity of the test used 
to provide laboratory confirmation of influenza infection in the 
cases is of great importance, as false positives can lead to sub-
stantial bias in the results.32 Third, because household member 
vaccination status was collected by self-report and not verified 
by physician records and because the date of household mem-
ber vaccination was not collected, some household members may 
have reported incorrect information about their vaccination sta-
tus and/or may have been vaccinated after the case was hospital-
ized. Fourth, recall bias may have affected parental responses to 
some questions; differential recall bias by case or control status 
is possible, as the controls as a group were interviewed later than 
cases were compared with the reference period. Fifth, selection 
bias is always a possibility in observational studies and may be of 
particular concern in  case-control studies. Children eligible to be 
controls of higher socioeconomic status may have been easier to 
TABLE 5. Matched Multivariate Regression Analysis 
of Factors Associated With Hospitalization With 
Laboratory-confirmed Influenza Virus Infection: Matched 
Multivariate Regression Main Effects Model Without 
Interaction Term
Risk Factor aOR (95% CI) P
Maternal age <26 years 1.8 (1.2–2.9) 0.01
Household income below the poverty 
threshold
2.2 (1.4–3.5) 0.001
Underlying medical conditions
  Hematologic or oncologic condition* 11.2 (4.3–29.2) <0.0001
  Pulmonary condition† 2.8 (1.9–4.2) <0.0001
  Neurologic condition‡ 3.8 (1.6–9.1) 0.003
  Other condition 5.7 (1.0–31.7) 0.046
>50% of household members smoked 2.9 (1.3–6.3) 0.009
No household member vaccinated for 
influenza
1.7 (1.2–2.4) 0.006
Child vaccinated for influenza 
(vs. unvaccinated reference group)
1.4 (0.9–2.1) 0.15
*Sickle cell disease, malignancy, history of bone marrow or organ transplant, 
chronic immunologic condition.
†Chronic asthma condition, chronic lung condition, birth defect or chronic condition 
making breathing or swallowing difficult, condition requiring equipment for breathing 
or handling secretions, condition that an operation was done to make breathing/secre-
tions easier, and condition requiring surgery or equipment for breathing/secretions.
‡Spinal cord injury, history of seizure, severe developmental delay or mental 
retardation.
aOR, adjusted OR.
TABLE 6. Matched Multivariate Regression Analysis 
of Factors Associated With Hospitalization With 
Laboratory-confirmed Influenza Virus Infection: Matched 
Multivariate Regression With Interaction Term
Risk Factor aOR (95% CI) P
Maternal age <26 years 1.8 (1.1–2.9) 0.01
Household income below the 
poverty threshold
2.2 (1.4–3.6) 0.001
Underlying medical conditions
  Hematologic or oncologic 
condition*
11.8 (4.5–31.0) <0.0001
  Pulmonary condition† 2.9 (1.9–4.4) <0.0001
  Neurologic condition‡ 3.8 (1.6–9.2) 0.003
  Other condition 6.7 (1.1–39.6) 0.03
>50% of household members 
smoked
2.9 (1.4–6.6) 0.006
No household member 
 vaccinated for influenza
1.8 (1.2–2.5) 0.003
Child vaccinated for influenza 
(vs. unvaccinated reference 
group) by child age category
0.01§
  6–23 months of age 0.5 (0.3–0.9) 0.01
  24–59 months of age 1.5 (0.8–3.0) 0.24
*Sickle cell disease, malignancy, history of bone marrow or organ transplant, 
chronic immunologic condition.
†Chronic asthma condition, chronic lung condition, birth defect or chronic condition 
making breathing or swallowing difficult, condition requiring equipment for breathing 
or handling secretions, condition that an operation was done to make breathing/secre-
tions easier, and condition requiring surgery or equipment for breathing/secretions.
‡Spinal cord injury, history of seizure, severe developmental delay or mental 
retardation.
§P value for the interaction term = 0.01
aOR, adjusted OR.
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reach and enroll than other eligible controls, which would likely 
bias the strength of associations, especially for sociodemographic 
indicators, away from the null. However, it is also possible that 
case children of lower socioeconomic status were less likely to be 
enrolled if their caregivers were more difficult to reach because of 
lack of contact information or difficulty traveling to the hospital. 
As a lower proportion of controls were enrolled compared with 
cases, the potential for selection bias may be a greater concern 
among controls.
However, a strength of our study is that the eligible con-
trols represented the true population from which the cases arose 
and included all children exposed to influenza viruses. Recently, a 
variation of traditional case-control study design known as the test 
negative design has become widely used in studies of influenza 
vaccine effectiveness. In such studies, all subjects are tested for 
influenza infection; cases are those testing positive and “controls” 
are those testing negative.33,34 These studies are popular because 
they permit investigators to enroll cases and non-cases from only 
those persons tested for influenza. For example, in a study of risk 
factors for influenza-related hospitalizations, one would only 
enroll children tested in the hospital for influenza infection. Such 
studies do have limitations, however, and by not limiting control 
selection to children tested for influenza, we were able to evaluate 
factors that might lead children to have more intense exposure to 
influenza viruses (such as daycare attendance or household crowd-
ing) as well as factors potentially associated with more severe 
influenza infections (including chronic illnesses and having house-
hold members who smoke).
We found child, caregiver and household factors associated 
with hospitalization with influenza infection among young chil-
dren eligible for influenza vaccination (ie, 6 months of age and 
older). Our findings that chronic illnesses, young maternal age, 
poverty, household smoking and lack of household member influ-
enza vaccination increase the risk of an influenza hospitalization 
may help providers to identify young children at greatest risk for 
poor outcomes from influenza illness, including those for whom 
early interventions such as treatment with influenza antivirals is of 
paramount importance.
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APPENDIX
METHODS: COUNTIES PARTICIPATING IN  
THE EIP  PEDIATRIC INFLUENzA HOSPITALIzED  
SURvEILLANCE PROjECT
Selected counties in 9 states that participated in the EIP Pedi-
atric Influenza Hospitalized Surveillance Project: California (Alam-
eda, Contra Costa, San Francisco); Colorado (Adams, Arapahoe, 
Denver, Douglas, Jefferson); Connecticut (New Haven); Georgia 
(Clayton, Cobb, DeKalb, Douglas, Fulton, Gwinnett, Newton, Rock-
dale); Minnesota (Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, 
Washington); New Mexico (2006–08: Bernalillo, Doña Ana, Grant, 
Luna; 2007–2008: Chaves and Santa Fe added), New York (Gene-
see, Livingston, Monroe, Ontario, Orleans, Wayne, Yates), Oregon 
(2005–2006: Clackamas, Multnomah, Washington; 2006–2008: all 
36 Oregon counties) and Tennessee (Cheatham, Davidson, Dickson, 
Robertson, Rutherford, Sumner, Williamson, Wilson).
CODE FOR MULTIvARIAbLE ANALySES PRESENTED 
IN TAbLES 5 AND 6
Table 5: Matched multivariable regression analysis of factors 
associated with hospitalization with laboratory-confirmed influenza 
virus infection, main effects model without interaction term
proc logistic data=a;
model enrolltype = perccat hemeonccat lungcat neurocat 
othchron totalpersonsvax matagecat poverty_status immunstatus / 
clodds=wald;
strata CaseID;
run;
Table 6: Matched multivariable regression analysis of fac-
tors associated with hospitalization with laboratory-confirmed 
influenza virus infection, with interaction term
proc logistic data=a;
model enrolltype = perccat hemeonccat lungcat neurocat 
othchron totalpersonsvax matagecat
poverty_status immunstatus agegrouprecat 
agegrouprecat*immunstatus / clodds=wald;
strata CaseID;
CONTRAST agegrouprecat 0 immunstatus -1 
agegrouprecat*immunstatus -1 / estimate=exp;
CONTRAST agegrouprecat 0 immunstatus -1 
agegrouprecat*immunstatus 0 / estimate=exp;
run;
Variables key
perccat: >50% of household members smoked
hemeonccat: hematologic or oncologic condition
lungcat: pulmonary condition
neurocat: neurologic condition
othchron: other condition
totalpersonsvax: no household member vaccinated for influenza
matagecat: maternal age<26 years
poverty_status: household income below the poverty threshold
immunstatus: child vaccinated for influenza (vs. unvacci-
nated reference group)
agegrouprecat: age category of child (6–23 months vs. 
24–59 months)
